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A CARBOHYDRATE-RICH protein layer has been detected on the surface ofmany
cell types (Rambourg and Leblond, 1967; Fawcett, 1964). Bennett (1963)
compared this layer to a similar coat around protozoa and he called it the glyco-
calyx (" sugar-coated "), suggesting that it may be a universal feature of animal
cells. Gasic and Beydak (1961) have drawn attention to the glycocalyx ofseveral
types ofexperimental tumour and demonstrated that it was rich in sialic (N-acetyl
neuraminic) acid. This sialic acid is the major factor determining the net
negative surface charge of many animal cell types and may well be involved in
the abnormal social behaviour oftumour cells in vitro (Abercrombie and Ambrose,
1962). Furthermore, it has been postulated that the sialic acid content of the
periphery of tumour cells may act in some way as a barrier to the detection of
antigens by the host organism and thus help to explain the immunological paradox
implicit in the growth and development of potentially antigenic tumours (Currie
and Bagshawe, 1967). Studies from several laboratories have recently shown that
enzymatic removal of sialic acid from the surface of some transplantable mouse
tumours results in great enhancement of their immunogenicity and lend support
to the " antigen-masking" hypothesis (Currie, 1967; Lindenmann and Klein,
1967; Sanford, 1967).
The purpose of this communication is to extend these studies in an attempt
to define the role of sialic acid in the cell periphery as a barrier to the detection
ofantigens on a " non specific " transplantable tumour.
MATERIALS AND METHODS
Mice
All the animals in these experiments were young adult female inbred A2 G
strain mice weighing approximately 28-30 g. They were randomly distributed
in groups of 5 in polythene cages.
Tumour
The Landschutz ascites tumour has been maintained in these laboratories for
approximately 50 passages. It was grown in young female adult A2 G mice, being
passaged every 7 days by the intraperitoneal administration of 0 2 ml. of fresh
undiluted ascitic fluid. The tumour cells employed in this study were obtained
by aspiration of ascitic fluid 6 days after inoculation. The cells were routinely
washed 6 times in Hank's Balanced Salt Solution (HBSS) and counted in a
haemocytometerbefore use.G. A. CURRIE AND K. D. BAGSHAWE
Enzymes
The following enzymes were used:
(a) Vibrio cholerae neuraminidase (VCN). This was obtained (Behringwerke-
Batch 966c) and used in 0-05 M sodium acetate-acetic acid buffered saline at
pH 5 5, containing 1 mg./ml. calcium chloride. Each ml. of this preparation
contained 500 " units " of enzyme activity. One unit of activity is defined as
the amount ofenzyme which will release 1 fig. ofN-acetyl neuraminic acid (NANA)
from an al glycoprotein in 15 minutes at 370 C. It is a purified preparation
containing no other glycolytic or proteolytic activity. It is also free of NANA-
aldolase.
(b) Clostridiumperfringens neuraminidase (CPN) (Sigma type VI) is a chromato-
tographically purified enzyme preparation. It was dissolved in acetate-buffered
saline to a concentration equivalent to 500 units/ml. (as defined above).
(c) Inactivated influenza virus (Flugen-Burroughs Wellcome) was used as a
source of influenza neuraminidase (FLU N). This preparation contained sub-
strains of A2 and B/England viruses. Each ml. contained 15,000 HA units
(haemagglutination).
(d) Trypsin (Difco 1: 250) was made up in HBSS to 0-2 per cent at pH 7 2.
(e) Ribonuclease (RNAse). The preparation was a four times recrystallized
extract of bovine pancreas (B.D.H.) and was used as a 1 mg. per ml. solution in
HBSS at pH 7-2.
(f) Hyaluronidase. Bovine hyaluronidase 1500 units/ml. (Fisons) was made
up in HBSS at pH 7-2.
Enzyme treatment oftumour cells.
Washed cells were suspended in the enzyme preparations at 370 C. with gentle
mixing in a roller-tube incubator. After, and between, series of treatments the
cells were washed 6 times in at least 50 volumes ofHBSS. Twenty million tumour
cells were incubated in each ml. of enzyme solution.
Viability
After all treatments the cells were tested for their ability to exclude trypan
blue. Dye exclusion " viabilities " are expressed as the number of dye-excluding
cells as a percentage of the total cell count. Control cells were incubated in the
appropriate buffers (i.e. acetate buffered saline or HBSS) and their dye-exclusion
" viabilities " also measured.
Electrophoretic mobility of tumour cells
Electrophoretic mobilities were measured in a cylindrical microelectrophoresis
apparatus (Bangham et al., 1958). The cells were suspended in HBSS at pH 7-2
and their mobilities measured in both directions. The results are the mean of 20
observations on each preparation and are expressed in /t/sec./v/cm.
Testfor imrnunogenicity
Immunogenicity is a relative term especially when applied to tumours.
Therefore an entirely empirical system was employed in the present experiments.
Each mouse received 4 X 106 cells, either treated or control, and was observed
for tumour development for 30 days. The mice which survived 30 days after
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this inoculation and were clinically tumour-free were then rechallenged by the
intraperitoneal injection of 5 X 104 untreated cells (approximately 5000 times
the LD50 for this tumour). These mice were then observed for a further 60 days.
All mice which survived this period were considered to be " immune " and the
cell preparation which induced such a state was termed " immunogenic ". No
mouse which was immune in this system has subsequently developed tumour,
either peritoneal or at the injection site (up to 300 days later).
RESULTS
Vibrio cholerae neuraminidase (VCN) (Table I)
Incubation in VCN for 30 minutes caused a marked fall in the electrophoretic
mobility of the Landschuitz tumour cells (Table IV). Their dye-exclusion
TABLE I.-Effects of Vibrio cholerae Neuraminidase (VCN) on the
Immunogenicity ofLandschiltz Tumour Cells
Rechallenge
Treatment of Mice surviving with
cells Temperature 0 C. Time (minutes) Dye exclusion at day 30 5 x 104 cells
Acetate buffer . 37 30 93 0/40*
VCN . . . 37 30 94 39/40 36/39*
VCN . . . 4 30 86 0/5
VCN. . 37 30 94
mixedwith equal 5/5 5/5
numbers ofacetate 37 30 93J
buffer treated cells
* Number of mice surviving free of tumour/number of mice injected.
"viability " was not significantly different from the control cells incubated in
buffer alone. However this VCN treatment greatly enhanced the immunogenicity
of the cells, inducing a powerful anti-tumour immunity in all the injected mice.
Incubation in VCN at 40 C. for 30 minutes had no effect on the in vivo development
ofthe tumour cells indicating that the enzyme activity is temperature dependent.
When cells, treated with VCN at 370 C. for 30 minutes and washed thoroughly,
were mixed with an equal number of untreated cells the resulting cell suspension
was still highly immunogenic, illustrating that only a proportion ofthe inoculated
cells need to be subjected to neuraminidase treatment to inhibit subsequent
tumour development.
Other types of neuraminidase (Table II)
When tumour cells were incubated with an inactivated influenza virus prepara-
tion, a potent source ofinfluenza virus neuraminidase (FLU N), for 30 minutes at
370 C. there was no effect on the subsequent growth of the cells in vivo. Even
after incubation for 180 minutes there was no evident effect. Clostridium perfrin-
gens neuraminidase (CPN) treatment at 370 C. for 30 minutes similarly failed to
modify the subsequent growth of the cells in the recipient mice. Re-treatment
of similar CPN-treated cells with VCN for a further 30 minutes did render the
cells powerfully immunogenic implying that the neuraminidase substrate-sites
on-the cells involved in their immunogenicity were not blocked by inactive CPN.
However, prolonged incubation in CPN for 180 minutes resulted in no tumour
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TABLE II.-Effects of Different Types of Neuraminidase on the Landschfttz Tumour
Rechallenge
Treatment of Temperature Time Mice surviving with
cells (0 C.) (minutes) Dye exclusion at day 30 X 104 cells
VCN . 37 30 94 39/40 36/39
FLU N . 37 30 88 0/10
CPN . 37 30 89 0/10
FLU N . 37 180 82 0/5
CPN . 37 180 75 9/10 8/9
Acetate Buffer . 37 180 72 0/10
CPN for 30 minutes
washed and then 37 30 84 5/5 5/5
incubated in VCN
growth and subsequent immunity of the host mice. The " viabilities" of these
cells were reduced after 180 minutes but control cells, in the acetate buffer only,
which were similarly affected readily produced ascitic tumour and death in all
the inoculated mice. Thus the conditions of prolonged incubation at an acid
pH cannot account for the effects of CPN treatment for 180 minutes.
Trypsin
(a) Mucin Release.-Weiss (1958) has described the release ofa web ofmucinous
material from the surface ofascites tumour cells in vitro by incubation with trypsin.
Treatment ofLandschutz ascites tumour cells in 0-2 per cent trypsin for 60 minutes
at 370 C. produced a similar fine clot ofsuch material in the suspension. However,
when the cells had been pretreated with VCN for 30 minutes the amount of muci-
nous material released by trypsin was greatly increased. Difficulty was experi-
enced in obtaining adequate numbers offreely suspended cells from such prepara-
tions as they tended to adhere to, and became involved in, the massive clot.
This was overcome by increasing the number of cells employed (100 X 106) and
the volume of trypsin (5 ml.) and gently agitating the preparation to release
enough cells for subsequent experiments.
(b) Immunogenicity (Table III).-When Landschutz tumour cells were incu-
bated in 0-2 per cent trypsin at 370 C. for 60 minutes no effect on their subsequent
growth in mice was detectable, i.e. trypsin alone had no apparent effect on their
immunogenicity. However, subsequent treatment of these trypsinized cells
with VCN for 30 minutes greatly increased their immunogenicity in vivo. VCN
treated cells, however, lost their immunizing ability, after incubation in trypsin,
suggesting that the antigenic sites exposed by VON treatment are hydrolysed by
the trypsin. VCN pretreated cells, trypsinized and subsequently incubated in
VCN for a further 30 minutes remained non-immunogenic and produced tumour
in all the recipient mice, implying that all available antigenic sites were exposed
by the preliminary VCN treatment and then degraded by trypsin. Similarly,
trypsinized cells rendered immunogenic by VCN treatment, when incubated in
trypsin again losttheirabilityto induce immunity andkilled all the mice.
Ribonuclease andhyaluronidase (Table IV)
Incubation in ribonuclease (RNAse) for 60 minutes produced a fall in the
electrophoretic mobility of the tumour cells. On inoculation into mice, however,
such cells produced death from malignant ascites in the same manner as untreated
cells. Hyaluronidase treatment for 60 minutes produced no change in electro-
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TABLE IIL.-Effects of Trypsin and Various Sequential Trypsin/VCN Treatments
on the Immunogenicity of the Tumour Cells
Rechallenge Treatment of Dye Exclusion Mice surviving with
cells Temperature 0 C. Time (minutes) per cent at day 30 5 x 104 cells
VCN. . . 37 30 94 39/40 36/39
Trypsin . . 37 60 88 0/10
VCN. . 37 30
and . 80 0/5
Trypsin . 37 60J
Trypsin . . 37 60
and 86 .5/5 5/5
VCN . . 37 30J
Trypsin . . 37 60'
and
VCN 37 30 72 0/5
and
Trypsin . 37 60
VCN. . . 37 30
and
Trypsin . . 37 60 74 0/5 and
VCN . . 37 30
TABLE IV.-Effects of Ribonuclease and Hyaluronidase on the Electrophoretic Mobility and
on Subsequent Tumour Growth in vivo
Electrophoretic Mice Rechallenge Treatment of Dye exclusion mobility surviving with cells Temperatue 'C. Time (minutes) per cent Au/sec./v/cm. at day 30 5 x 104 cells
HBSS . . 37 30 97 -1*317 0/10
VCN . 37 30 94 -0* 690 39/40 36/39 Ribonuclease . 37 60 89 -1b026 0/10 Hyaluronidase . 37 60 87 -1*314 0/10
phoretic mobility and had no effect on the ability of the cells to develop and kill
all theinjected mice.
DISCUSSION
Langley and Ambrose (1967) have studied the linkages of sialic acid on the
surface of the Ehrlich ascites tumour and concluded that it mainly occupied the
terminal positions on the oligosaccharide prosthetic groups of cell surface glyco-
proteins. Hydrolysis of these prosthetic groups revealed that the sialic acid was
predominantly associated with N-acetyl D-galactosamine and that the molar
ratio of these sugars approached unity. They therefore inferred that the pros-
thetic groups were disaccharides with sialic acid occupying the terminal non-
reducing position (i.e. as N-acetyl neuraminosyl 2-? N-acetyl D galactosaminoyl-).
They also detected the presence of N-glycolyl neuraminic acid on the same cells
but indicated that its concentration was much less than sialic (N-acetyl neura-
minic) acid. They also showed that the sialic acid content was associated with
trypsin-labile proteins and not with cell wall lipids, thus confirming the observa-
tions of Gray (1963) who found only minute quantities of glycolipid in similar
tumour cells.G. A. CURRIE AND K. D. BAGSHAWE
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FIG. 1. A simplified glycoprotein prosthetic group (N-acetyl neuraminosyl 2-6 N-acetyl
D galactosaminoyl-) showing the followingfeatures. (1) N-acetyl neuraminic acid carboxyl
group (2) 2-6 0-glycoside bond which is (3)-Site of action of neuraminidase. (4) Prob-
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FIG. 2. Simplified diagram of the possible relationship between a disaccharide prcsthetic
group (N-acetyl neuraminosyl 2-6 N-acetyl D galactosaminov]) and an underlying trypsin
sensitive site (tss) in the glycoprotein peptide chain. Access of trypsin to the tss (as shown
on the right) is inhibited by the terminal sialic acid moiety. Host recognition of antigenic
determinant activity involving the tss could be similarly inhibited by steric hindrance.
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The action of neuraminidase is to catalyse the hydrolytic cleavage of 0-gly-
coside bonds between the potential keto-groups of N-acylated neuraminic acids
and adjacent sugar residues (Gottschalk, 1960). Treatment of the Landschutz
ascites tumour with neuraminidase derived from Vibrio cholerae (VCN) results in
greatly enhanced immunogenicity of the cells when they are subsequently inocu-
lated into mice. Thus, a potent anti-tumour immunity can be induced in the
recipient animals by the administration of VCN-treated cells. It was previously
demonstrated (Currie and Bagshawe, 1967; Bagshawe and Currie, 1968) that
VCN treatment did not modify the viability of the cells or their ability to grow
in immunosuppressed animals. The admixture of VCN-treated (and washed)
tumour cells with an equal number of untreated cells did not modify the ability
of recipient mice to develop immunity. As the inoculation of these mice with
treated and untreated cells together failed to induce tumour, then the immunizing
properties of the VCN-treated cells must have been sufficient to allow the host
to overcome the growth of the untreated cells and would imply that the enhanced
immunogenicity of the treated cells need not be dependent upon modification of
their growth potential. This is further supported by the observations of Kraemer
(1966) who demonstrated that neuraminidase-treated cells will grow readily in
tissue culture.
The masking of antigenicity must therefore be associated with the presence of
N-acylated neuraminic acids in the surface glyocproteins of the tumour cells.
In the present studies there were dramatic differences between the effects of
different species of neuraminidase on the immunogenicity of the Landschutz
tumour. Clostridiurn perfringens neuraminidase (CPN) under incubation condi-
tions identical to the VCN experiments (i.e. 30 minutes) failed to increase the
immunogenicity of the tumour. However, incubation with CPN for 3 hours did
apparently unmask the antigenicity of the cells. Inactivated influenza virus,
rich in viral neuraminidase (FLU N) failed to modify the immunogenicity of the
tumour cells even after incubation for long periods. An explanation for these
important differences may be found by examining the site of action of neuramini-
dase on the substrate. Sialic acid may be linked to sugar residues by several
types of0-glycoside bond. In most biological systems studied so far the common-
est types of neuraminidase-sensitive bond are between the number 2 carbon
atom of sialic acid and either the 3 or the 6 carbon atom of the adjacent amino-
sugar (Gottschalk, 1960). VCN is known to cleave both the 2-3 and the 2-6
bonds readily (Drzeniek, 1967), whereas myxovirus neuraminidases, including
FLU N, only cleave 0-glycoside bonds ofthe 2-3 type. Burton (1963) has exam-
ined the time course ofhydrolysis ofboth 2-3 and 2-6 bonds by OPN and revealed
dramatic differences. Incubation with CPN for 30 minutes in his system resulted
in release of approximately 90 per cent of 2-3 bound sialic acid but only minute
amounts of that linked by the 2-6 bond. However after 3 hours incubation the
percentage of 2-6 bound sialic acid released rose to 95-100 per cent. Thus
incubation ofthe Landschiitz tumour cells in CPN for 30 minutes may only remove
2-3 bound sialic acid. Only after 3 hours' incubation is the 2-6 bond hydrolysed
and the tumour cells rendered immunogenic. After CPN treatment of the cells
for only 30 minutes however the cells were still susceptible to the unmasking
effects of VCN, implying that the substrate sites were not blocked by inactive
(or slow acting) CPN molecules. Hydrolytic cleavage of the disaccharide pros-
thetic group N-acetyl neuraminosyl 2-3 N-acetyl D galactosaminoyl alone, as
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would occur with FLU N, or CPN incubated for 30 minutes, is therefore insufficient
to modify the immunogenicity of the tumour cells. Cleavage of N-acetyl neura-
minosyl 2-6 N acetyl D galatosaminoyl- as well as the 2-3 prosthetic group must
take place before the cells are capable of immunizing the recipient mice. It
is not yet clear whether release of the 2-6 bound sialic acid alone is sufficient to
unmask antigenic sites. Consequently it is not yet possible to explain the role
played by the different types of 0-glycoside bond in the immunogenicity of these
tumour cells. A quantitative steric difference in the three dimensional positions
of 2-3 and 2-6 bound sialic acid may account for this phenomenon. However,
it is not inconceivable that a quantitative effect of the total concentration of
sialic acid in the cell periphery, regardless of the type of bond, may be operating
in the present system.
Gottschalk and Fazekas de St Groth (1960) have studied tryptic hydrolysis of
a submaxillary sialomucin. The number of potential trypsin-sensitive sites
cleaved was determined by assay of amide residues. They revealed that the
number of sites hydrolysed by trypsin was greatly increased after prior neura-
minidase treatment of the sialomucin. They therefore postulated that sialic
acid inhibits tryptic hydrolysis by steric hindrance, i.e. the prosthetic group
terminal sialic acid blocked underlying substrate sensitive sites from contact with
the active centre ofthe trypsin molecule. Itis ofinterest thattheprosthetic groups
they described were identical to those found by Langley and Ambrose (1967) on
ascitic tumour cells. Furthermore the 0-glycoside bond between the saccharides in
this prosthetic group was ofthe 2-6 type. In the present experiments the amount
of mucinous material released from tumour cells by trypsin was grossly increased
by pre-treatment of the cells with VCN. This finding suggests that the labile
sites on cell wall mucins were protected in a similar manner by neuraminidase
sensitive sialic acid, i.e. steric hindrance.
The immunogenicity ofVCN-treated Landschutz cells was abolished by trypsin
treatment but pretreatment of the cells with trypsin did not abolish the effects
of a subsequent VCN treatment, implying that the sensitive antigenic determinant
sites were protected from the action of trypsin by sialic acid. Trypsin treatment,
followed by VCN and then retrypsinization resulted in "non-immunogenic "
cells and subsequent death of the recipient mice. Trypsinized VCN-pretreated
cells could not, moreover, be rendered immunogenic by subsequent VCN treat-
ments. This suggests that the preliminary VCN treatment exposed all available
antigenic sites to the disruptive effects of trypsin. These results may be inter-
preted, in the light of Gottschalk and Fazekas de St. Groths' (1960) work on
sialomucins, as implying that steric factors are involved in inhibiting access of
the active centre of trypsin to sensitive sites in the antigenic areas. However
Neurath and Schwert (1950) have pointed out that tryptic hydrolysis may be
inhibited by the electrostatic effects of ionized carboxyl groups in the region of
the sensitive site. The powerfully ionogenic carboxyl group of the terminal
sialic acid could possibly provide such electrostatic effects. At the moment it
is not possible to dissociate steric hindrance from the local effects of charged
groups. The molecular basis of enzyme-substrate interactions is similar in many
ways to the relationship between an antigen and its complementary receptor site.
It seems feasible that mechanisms hindering the enzymatic degradation of a
given antigenic site would also inhibit immunological interactions involved in the
detection of antigens with the same antigenic determinant groups.
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The nature of the antigen(s) exposed by the action of neuraminidase on the
Landschiitz tumour has not yet been explored. This tumour is a non-specific
transplantable neoplasm which probably represents a malignant allograft. There-
fore its antigenicity may well be related to the mouse histocompatibility antigen
system. Nathensen and Davies (1966) have studied the chemical structure
of solubilized H2 mouse isoantigens and believe them to be glycoproteins.
The nature of the specific determinant groups on these glycoproteins is not
yet clear but the hexosamine content of the prosthetic groups may be involved
in such specificity. These preparations do contain sialic acid but neuramini-
dase treatment does not affect their antigenic activity (Davies, 1967).
Thus the neuraminidase-sensitive sialic acids in these histocompatibility antigen
preparations are probably not directly involved in the antigenic determinant
site, although their underlying hexosamines may play a part. Therefore the
elucidation of the structure of cell wall glycoproteins may have important impli-
cations for understanding the nature of antigenic determination and investigation
of the role of sialic acid in thise glycoproteins may give some clues as to how the
the expression of such antigenicity is moderated.
Neuraminidase treatment will expose antigens on the red cell. Saber, Drzeniek
and Krupe (1965) have shown that carbohydrate groups demonstrating ABH
blood-group specificity may be unmasked by treatment of several species of
erythrocytes with neuraminidase. Similarly, treatment of erythrocytes will
expose Forssmann antigen activity under conditions where untreated cells show
no such activity (Drzeniek et al., 1966). Burnet and Anderson (1947) have also
shown that treatment of red cells with R.D.E. (receptor destroying enzyme
neuraminidase) will bring about T-agglutination in many normal mammalian
sera. They postulated that the enzyme had exposed a previously undetectable
surface antigen on the red cells. It could be postulated that the effects of VCN
on the Landschutz ascites tumour are also due to a form of T-agglutination.
Our previous studies indicate that this is not so. The growth of VCN-treated
cells in irradiated (Bagshawe and Currie, 1968) or hydrocortisonized mice (Currie
and Bagshawe, 1968) and the lack of high titre agglutination of normal mouse
sera for VCN-treated cells would indicate that factors other than T-agglutination
must be involved.
Although the present studies have been confined mainly to sialic acid it is not
inconceivable that other cell surface components may modify the expression of
antigenicity by cells. Weiss (1968) has indicated that RNA may be an integral
part of the cell periphery in several cell types. The effects of RNAse on the
electrophoretic mobility of the Landschutz tumour suggest that RNA may well
be present on the cell surface. However RNAse had no effect on the immuno-
genicity of this tumour. Hyaluronidase had no effect on either its electrophoretic
mobility or its immunogenicity indicating the probable absence of hyaluronic
acid from the glycocalyx of this particular tumour. However the chemical
structure of the cell surface is undoubtedly very complex and further work is
needed to evaluate the role of various other cell surface components in modifying
the immunogenic properties of cells.
The relationship between the cell surface glycoproteins in the glycocalyx and
such surface phenomena as contact inhibition, intercellular adhesiveness and
antigenicity is not yet clear. Extensive studies of the action of neuraminidase
on glycoprotein prosthetic groups on the cell surface may provide valuable inform-
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ation about the molecular structures responsible for moderating such cellular
interactions and maygive someinsight into the " chemistry ofantigenicity ".
SUMMARY
Experiments were performed to elucidate the role of sialic acid and its mode
of linkage to the cell surface in inhibiting the detection of antigens on the Land-
schuitz ascites tumour by the host's immunological mechanisms. The immuno-
genicity of this tumour was greatly enhanced after in vitro incubation in neura-
minidase. The antigenic sites exposed by neuraminidase were destroyed by
trypsin. However, prior treatment with trypsin did not affect the subsequent
exposure of antigen(s) by neuraminidase. Various sequential enzyme treatments
of the tumour cells with trypsin and/or neuraminidase suggest that the trypsin-
sensitive components of the antigenic determinant groups are protected from the
active centre of the trypsin molecule by neuraminidase-susceptible sialic acids.
It is proposed that these antigenic sites may be protected from the host's immuno-
competent cells in a similar manner.
Neuraminidases derived from different species of micro-organism display
different effects on the immunogenicity of this tumour. Vibrio cholerae neura-
minidase readily unmasked the antigenic sites on the tumour cells. The enzyme
which comprises part of the influenza virion had no effect, whereas Clostridium
perfringens neuraminidase only produced an effect after prolonged incubation.
These enzymes have different substrate specificities and it is suggested that the
enzymatic removal of cell wall sialic acid bound to hexosamines by a 2-3 0-gly-
cosidic linkage is insufficient to unmask antigernic sites. Hydrolysis of the 2-6
bonds appears to be essential.
Ribonuclease and hyaluronidase treatment in vitro had no effect on the subse-
quent in vivo development of tumour cells. It was incidentally revealed that
ribonucleic acid is probably present in the cell periphery of the Landschuitz
tumour cells.
It is suggested that the neuraminidase-sensitive terminal sialic acid moiety
of cell surface glycoprotein prosthetic groups inhibits access to underlying anti-
genic determinant areas; this phenomenon probably depending on the type of
0-glycoside bond between the sialic acid and underlying hexosamines. Although
it is not yet possible to rule out the local inhibitory electrostatic effects of the
carboxyl groups of sialic acid it seems probable that the blocking effects of this
sialic acid are due to steric hindrance.
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